Click Here to return To Results

 

Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992 See this aricle in Pubmed Article Abstract Depending on the rate of haemorrhagic complications 34 to 83 patients would need to be treated annually with anticoagulants to prevent one stroke;83 patients would need to be treated with aspirin.Giving anticoagulant treatment only would reduce costs by Kr60 million if the incidence of intracranial haemorrhage were 0.3%but would imply a net expense if the complication rate exceeded 1.3%.The total savings from giving anticoagulant(22,000 patients)and aspirin(55,000 patients)treatment would be Krl75 million per year corresponding to 2 million per million inhabitants each year.Treatment with anticoagulants and,if contraindications exist,with aspirin is cost effective provided that the risk of serious haemorrhage complications due to anticoagulants is kept low.

Related Tags

(click to filter results - removes previous filter) anticoagulant,complications of anticoagulant,treatment anticoagulant,treatment in CVD aspirin atrial fibrillation cerebrovascular accident cerebrovascular accident,prevention of cost effectiveness coumarin treatment of neurologic disorder

Click Here to return To Results